566 filings
Page 3 of 29
SC 13G/A
t6napo5hzaq c5x86f
22 Dec 23
Neurogene / Redmile ownership change
4:15pm
SC 13D
myu1v90
21 Dec 23
Neurogene / McMinn Rachel ownership change
4:05pm
4
mh0taifu1e7p8vsy4d
20 Dec 23
Neurogene / JULIAN BAKER ownership change
6:43pm
SC 13D/A
zwtlw79zpe
20 Dec 23
Neurogene / BAKER BROS. ADVISORS ownership change
5:24pm
8-K
x9kmd6
19 Dec 23
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
7:31am
425
240ed8lvwv
6 Dec 23
Business combination disclosure
4:24pm
8-K
9pke3b2ffzi32ca
6 Dec 23
Other Events
4:21pm
425
q5qbgtd ic039lav3vl
4 Dec 23
Business combination disclosure
5:14pm
8-K
1y4jaomkfah8t 2cl
4 Dec 23
Other Events
5:10pm
425
bwged2x5ek98z0 mf
30 Nov 23
Business combination disclosure
4:06pm
EFFECT
r0j gx0sj
14 Nov 23
Notice of effectiveness
12:15am
SEC STAFF LETTER
kyw4m4
13 Nov 23
SEC staff letter
12:00am
CORRESP
j2w9d f09xkomdqp10q8
8 Nov 23
Correspondence with SEC
12:00am
CORRESP
ylqdpramm53x
8 Nov 23
Correspondence with SEC
12:00am
CORRESP
ci48j6eyuycwklu
18 Oct 23
Correspondence with SEC
12:00am
SC 13D/A
p0dmoz7d3p3z
10 Oct 23
Neoleukin Therapeutics / BAKER BROS. ADVISORS ownership change
4:42pm
4
259gf1w3f
10 Oct 23
Neoleukin Therapeutics / JULIAN BAKER ownership change
4:22pm